WeLeader Biomedical Co., Ltd. (TPEX:7713)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
67.50
0.00 (0.00%)
Apr 29, 2026, 1:00 PM CST
17.60%
Market Cap 3.07B
Revenue (ttm) 1.11B
Net Income (ttm) 208.56M
Shares Out 45.48M
EPS (ttm) 4.52
PE Ratio 14.92
Forward PE n/a
Dividend 4.10 (6.07%)
Ex-Dividend Date Mar 27, 2026
Volume 5,245
Average Volume 15,623
Open 67.00
Previous Close 67.50
Day's Range 67.00 - 67.50
52-Week Range 55.90 - 83.00
Beta 0.11
RSI 45.34
Earnings Date May 8, 2026

About WeLeader Biomedical

WeLeader Biomedical Co., Ltd. operates as an agent and distributor of in vitro diagnostic products. It offers a range of medical testing systems, such as serum biochemistry integration platform, clinical care, and medical information integration system. The company also provides blood gas electrolyte analyzers, urine analyzers, integrated fully automatic biochemical analyzers, fully automatic electronic luminescence immunoassay products, fully automatic modular biochemical immune assay products, TTA automated pre-processing products, POCT centr... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1992
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 7713
Full Company Profile

Financial Performance

In 2025, WeLeader Biomedical's revenue was 1.11 billion, an increase of 11.92% compared to the previous year's 991.13 million. Earnings were 208.56 million, an increase of 22.53%.

Financial Statements

News

There is no news available yet.